Prostate Cancer Trial, Recruiting NCT04858880 Sponsor: Lund University Hospital Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT04858880
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People with a life expectancy of more than 10 years
  • People who are generally well and able to carry out normal daily activities with little or no limitation (known as WHO performance status 0–1)
  • People whose prostate cancer was confirmed by laboratory testing of tissue removed during prostate surgery
  • People whose cancer, at the time of surgery, had not spread to nearby lymph nodes or to other parts of the body
  • People who have had a rise in their PSA blood test levels after prostate surgery, with PSA levels between 0.15 and 0.70 ng/ml (a specific measurement of a protein linked to prostate cancer)
  • People whose blood test results meet certain minimum standards for blood cell counts, liver function, and kidney function (confirm with trial site for exact values)
  • People who are able to follow the trial schedule and requirements
  • People who have given their written agreement to take part

Who may not be able to join:

  • People whose scans or imaging show cancer has spread to lymph nodes or other parts of the body
  • People who are currently receiving or have previously received hormone therapy for prostate cancer (such as antiandrogen or hormone-blocking treatments)
  • People who have previously had radiation therapy to the pelvic area
  • People who have been diagnosed with another cancer (other than prostate cancer or a specific type of non-melanoma skin cancer called basalioma) within the past five years
  • People with significant or active heart problems, such as a heart attack within the last six months, unstable chest pain, or moderate-to-severe heart failure
  • People with severe lung disease
  • People with any other serious or poorly controlled health condition that the trial doctor considers would make participation unsuitable

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +46 46 17 75 20

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Lund University Hospital
Registry
ClinicalTrials.gov
Start date
9 April 2021
Est. completion
1 April 2030

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Failure-free survival (FFS).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov